CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Jul 6, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
99.8%
-0.1% vs 52w high · +14.6% 1mo

Price (last ~year)

CVS Health Corp reported Q1 2026 revenue of $100.43 billion and earnings of $2.57 per share, exceeding analyst expectations. Shares have climbed 35% over the past three months to $104.72, currently trading near the 52-week high with a market capitalization of $133.62 billion. The company carries $78.34 billion in total debt and generated $3.40 billion in free cash flow for the quarter.

Valuation

Market cap
$133.62B
P/E
45.93
PEG
0.295
P/B
1.725
P/S
0.329
EV/EBITDA
17.98
Beta
0.598
Analyst target
$105.69

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$104.72
1-month
+14.6%
3-month
+35.0%
RSI (14)
65
vs SMA200
+29.7%
52-wk position
99.8% -0.1% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots